[Aldactone (spironolactone, canrenoate-K) in the treatment of chronic cor pulmonale].
D000284:Administration, Oral; D000368:Aged; D001158:Arteries; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D004338:Drug Combinations; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006914:Hydroxysteroids / Q000627:therapeutic use; D007275:Injections, Intravenous; D007664:Ketosteroids / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011278:Pregnanes / Q000627:therapeutic use*; D011422:Propionates / Q000627:therapeutic use; D011660:Pulmonary Heart Disease / Q000097:blood / Q000188:drug therapy*; D012119:Respiration / Q000187:drug effects; D013148:Spironolactone / Q000627:therapeutic use*
D004338:Drug Combinations; D006914:Hydroxysteroids; D007664:Ketosteroids; D011278:Pregnanes; D011422:Propionates; D002245:Carbon Dioxide; D013148:Spironolactone; D010100:Oxygen
Zur Behandlung des chronischen Cor Pulmonale mit Aldactone (Spironolacton, Canrenoat-Kalium.